RxSight, Inc.
RXST· Nasdaq
Released Feb 25, 2026, after the close
10-K filed Feb 25, 2026, 56 days after period end · 0001193125-26-071775
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | $32.61M | $40.21M | $28.58M | $16.09M |
| Net Income | -$9.15M |
RxSight, Inc. · CIK 1111485 · Engraved from SEC EDGAR
| -$5.94M |
| -$9.18M |
| -$15.61M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.